Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up
SUMMARY: Gastric cancer (CG) is the second leading cause of cancer deaths. The best treatment option for patients with advanced GC (AGC) is still surgery, which involves performing a gastrectomy and D2 lymphadenectomy (D2L). The aim of this study was to determine postoperative morbidity (POM) and 5-year OS in patients resected by AGC without neoadjuvant. Case series with follow-up of patients with AGC undergoing total or subtotal gastrectomies and D2L, consecutively at RedSalud Mayor Temuco Clinic, between 2008 and 2019. The outcome variables were POM and 5-year OS. Other variables of interest were surgical time, number of resected lymph nodes, hospital stay, and recurrence. Descriptive statistics was used, and Kaplan-Meier curves were calculated. In this analysis 38 patients (71.1 % men), with a median age of 65 years, were operated. The most frequent location was subcardial (50.0 %). The most frequent type of resection was total gastrectomy (60.5 %). The median of surgical time, number of resected lymph nodes and hospital stay; was 190 min, 32 and 6 days respectively. MPO was 18.4 %. With a median follow-up of 28 months, a recurrence of 44.7 % was verified; and 5-year OS for stages IIIA, IIIB and IV were 53.3 %, 46.1 % and 20.0 % respectively (p= 0,007). The results achieved, in terms of POM and OS series were similar to national and international series in which neoadjuvant therapies have not been applied.
Main Authors: | , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedad Chilena de Anatomía
2020
|
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022020000501479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0717-95022020000501479 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0717-950220200005014792021-06-10Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-UpManterola,CarlosClaros,Nataniel "Stomach Neoplasms"[Mesh]) AND "Stomach Neoplasms/surgery"[Mesh] “Lymph Node Excision"[Mesh] Gastric Cancers Surgery, Lymphadenectomy SUMMARY: Gastric cancer (CG) is the second leading cause of cancer deaths. The best treatment option for patients with advanced GC (AGC) is still surgery, which involves performing a gastrectomy and D2 lymphadenectomy (D2L). The aim of this study was to determine postoperative morbidity (POM) and 5-year OS in patients resected by AGC without neoadjuvant. Case series with follow-up of patients with AGC undergoing total or subtotal gastrectomies and D2L, consecutively at RedSalud Mayor Temuco Clinic, between 2008 and 2019. The outcome variables were POM and 5-year OS. Other variables of interest were surgical time, number of resected lymph nodes, hospital stay, and recurrence. Descriptive statistics was used, and Kaplan-Meier curves were calculated. In this analysis 38 patients (71.1 % men), with a median age of 65 years, were operated. The most frequent location was subcardial (50.0 %). The most frequent type of resection was total gastrectomy (60.5 %). The median of surgical time, number of resected lymph nodes and hospital stay; was 190 min, 32 and 6 days respectively. MPO was 18.4 %. With a median follow-up of 28 months, a recurrence of 44.7 % was verified; and 5-year OS for stages IIIA, IIIB and IV were 53.3 %, 46.1 % and 20.0 % respectively (p= 0,007). The results achieved, in terms of POM and OS series were similar to national and international series in which neoadjuvant therapies have not been applied.info:eu-repo/semantics/openAccessSociedad Chilena de AnatomíaInternational Journal of Morphology v.38 n.5 20202020-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022020000501479en10.4067/S0717-95022020000501479 |
institution |
SCIELO |
collection |
OJS |
country |
Chile |
countrycode |
CL |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-cl |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Manterola,Carlos Claros,Nataniel |
spellingShingle |
Manterola,Carlos Claros,Nataniel Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up |
author_facet |
Manterola,Carlos Claros,Nataniel |
author_sort |
Manterola,Carlos |
title |
Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up |
title_short |
Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up |
title_full |
Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up |
title_fullStr |
Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up |
title_full_unstemmed |
Results of Surgical Treatment of Advanced Gastric Cancer. Case Series with Follow-Up |
title_sort |
results of surgical treatment of advanced gastric cancer. case series with follow-up |
description |
SUMMARY: Gastric cancer (CG) is the second leading cause of cancer deaths. The best treatment option for patients with advanced GC (AGC) is still surgery, which involves performing a gastrectomy and D2 lymphadenectomy (D2L). The aim of this study was to determine postoperative morbidity (POM) and 5-year OS in patients resected by AGC without neoadjuvant. Case series with follow-up of patients with AGC undergoing total or subtotal gastrectomies and D2L, consecutively at RedSalud Mayor Temuco Clinic, between 2008 and 2019. The outcome variables were POM and 5-year OS. Other variables of interest were surgical time, number of resected lymph nodes, hospital stay, and recurrence. Descriptive statistics was used, and Kaplan-Meier curves were calculated. In this analysis 38 patients (71.1 % men), with a median age of 65 years, were operated. The most frequent location was subcardial (50.0 %). The most frequent type of resection was total gastrectomy (60.5 %). The median of surgical time, number of resected lymph nodes and hospital stay; was 190 min, 32 and 6 days respectively. MPO was 18.4 %. With a median follow-up of 28 months, a recurrence of 44.7 % was verified; and 5-year OS for stages IIIA, IIIB and IV were 53.3 %, 46.1 % and 20.0 % respectively (p= 0,007). The results achieved, in terms of POM and OS series were similar to national and international series in which neoadjuvant therapies have not been applied. |
publisher |
Sociedad Chilena de Anatomía |
publishDate |
2020 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022020000501479 |
work_keys_str_mv |
AT manterolacarlos resultsofsurgicaltreatmentofadvancedgastriccancercaseserieswithfollowup AT clarosnataniel resultsofsurgicaltreatmentofadvancedgastriccancercaseserieswithfollowup |
_version_ |
1755993222645022720 |